Cardiovascular Safety During and After Use of Phentermine and Topiramate

CONTEXT: Increases in heart rate were seen during the clinical program for fixed-dose combination phentermine (PHEN) and topiramate (TPM), an oral medication indicated for weight management; however, the effect on cardiovascular (CV) outcomes is uncertain. OBJECTIVE: The aim of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritchey, Mary E, Harding, Abenah, Hunter, Shannon, Peterson, Craig, Sager, Philip T, Kowey, Peter R, Nguyen, Lan, Thomas, Steven, Cainzos-Achirica, Miguel, Rothman, Kenneth J, Andrews, Elizabeth B, Anthony, Mary S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318778/
https://www.ncbi.nlm.nih.gov/pubmed/30247575
http://dx.doi.org/10.1210/jc.2018-01010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318778/
https://www.ncbi.nlm.nih.gov/pubmed/30247575
http://dx.doi.org/10.1210/jc.2018-01010

Ejemplares similares